Does RIPRETINIB Cause Extra dose administered? 357 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 357 reports of Extra dose administered have been filed in association with RIPRETINIB (QINLOCK). This represents 8.1% of all adverse event reports for RIPRETINIB.
357
Reports of Extra dose administered with RIPRETINIB
8.1%
of all RIPRETINIB reports
32
Deaths
65
Hospitalizations
How Dangerous Is Extra dose administered From RIPRETINIB?
Of the 357 reports, 32 (9.0%) resulted in death, 65 (18.2%) required hospitalization, and 1 (0.3%) were considered life-threatening.
Is Extra dose administered Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIPRETINIB. However, 357 reports have been filed with the FAERS database.
What Other Side Effects Does RIPRETINIB Cause?
Fatigue (582)
Alopecia (517)
Death (356)
Underdose (345)
Nausea (292)
Drug ineffective (291)
Disease progression (290)
Hospitalisation (280)
Neoplasm progression (263)
Constipation (249)
What Other Drugs Cause Extra dose administered?
TIRZEPATIDE (6,774)
DULAGLUTIDE (3,047)
LORATADINE (1,556)
DUPILUMAB (1,422)
FEXOFENADINE (1,413)
NAPROXEN (908)
POLYETHYLENE GLYCOL 3350 (589)
ACETAMINOPHEN (552)
DALFAMPRIDINE (519)
FLUTICASONE\SALMETEROL (499)
Which RIPRETINIB Alternatives Have Lower Extra dose administered Risk?
RIPRETINIB vs RISANKIZUMAB
RIPRETINIB vs RISANKIZUMAB-RZAA
RIPRETINIB vs RISDIPLAM
RIPRETINIB vs RISEDRONATE
RIPRETINIB vs RISEDRONIC ACID